SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001626199-21-000141
Filing Date
2021-11-10
Accepted
2021-11-10 16:07:02
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alpn-20211110.htm   iXBRL 8-K 40203
2 EX-99.1 ex991_20210930.htm EX-99.1 77164
6 alpineislogosma11a.jpg GRAPHIC 15826
  Complete submission text file 0001626199-21-000141.txt   289313

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20211110.xsd EX-101.SCH 1951
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20211110_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20211110_pre.xml EX-101.PRE 13082
7 EXTRACTED XBRL INSTANCE DOCUMENT alpn-20211110_htm.xml XML 11633
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 211396563
SIC: 2834 Pharmaceutical Preparations